Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema

Table 1

Clinical and laboratory characteristic of diabetic subjects and nondiabetic controls.

Parameter	DME ()	Control ()
Number of patients (men/women)	4/12	1/12	ns
Age (years)	71 (61–77)	71 (66–74)	ns
LogMAR BCVA	1.0 (0.6–1.0)	0.5 (0.5–0.6)
Chronic kidney disease	1 (6.2%)	0 (0.0%)	ns
Dyslipidemia	8 (50.0%)	4 (30.8%)	ns
Hypertension	14 (87.5%)	10 (76.9%)	ns
HbA (mmol/mol)	51.5 (43.0–63.3)	NA	NA
Serum albumin (g/L)	42.7 (41.1–44.6)	44.4 (39.6–45.2)	ns
CRP (mg/L)	1.6 (1.0–3.7)	2.0 (0.8–3.6)	ns

Data are expressed as median ± interquartile range or total number and %.
ns: not significant; , , and DME versus control patients; BCVA: best corrected visual acuity; CRP: C-reactive protein; HbA: glycated haemoglobin; logMAR: logarithm of the minimal angle of resolution; and NA: not assessed; chronic kidney disease was defined as either structural kidney damage or glomerular filtration rate < 1.0 mL⋅s⁻¹⋅1.73 m⁻² for ≥ 3 months.